Year: 2026
Type: review
Abstract: With the aging population accelerating, age has become a core factor influencing the clinical phenotypes, treatment responses, and prognoses of neuroimmune diseases (NDs), including those affecting the central nervous system (CNS) and peripheral nervous system (PNS). This cross-disease review summarizes the shared and specific age-related characteristics of NDs, focusing on the pathological basis of immunosenescence and neurodegeneration underlying age-related ND progression. We extract the clinical manifestations, immune and neural mechanisms of elderly ND patients, and evaluate the challenges and individualized adjustment principles of therapeutic strategies for this population. We explore the age-related immune dysregulation features between NDs and other systemic autoimmune diseases (e.g., systemic lupus erythematosus (SLE), type 1 diabetes (T1D)). This review aims to construct a cross-disease framework for the precision management of NDs in the aging era, identify research gaps and future directions, and emphasize age-adapted intervention strategies for optimizing the prognosis of elderly ND patients.
Source: Neuroscience Bulletin
Authors: Zihao Yu, Xiaoyu Huang, Hao Zhang, Fu-Dong Shi
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,490
Funders: AstraZeneca, Biogen
OpenAlex ID: W7225453193
